Literature DB >> 15589157

BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation.

James M A Turner1, Olga Aprelikova, Xiaoling Xu, Ruihong Wang, Sangsoo Kim, Gadisetti V R Chandramouli, J Carl Barrett, Paul S Burgoyne, Chu-Xia Deng.   

Abstract

In mammalian spermatogenesis, the X and Y chromosomes are transcriptionally silenced during the pachytene stage of meiotic prophase (meiotic sex chromosome inactivation, MSCI), forming a condensed chromatin domain termed the sex or XY body. The nucleosomal core histone H2AX is phosphorylated within the XY chromatin domain just prior to MSCI, and it has been hypothesized that this triggers the chromatin condensation and transcriptional repression. Here, we show that the kinase ATR localizes to XY chromatin at the onset of MSCI and that this localization is disrupted in mice with a mutant form of the tumor suppressor protein BRCA1. In the mutant pachytene cells, ATR is usually present at nonsex chromosomal sites, where it colocalizes with aberrant sites of H2AX phosphorylation; in these cells, there is MSCI failure. In rare pachytene cells, ATR does locate to XY chromatin, H2AX is then phosphorylated, a sex body forms, and MSCI ensues. These observations highlight an important role for BRCA1 in recruiting the kinase ATR to XY chromatin at the onset of MSCI and provide compelling evidence that it is ATR that phosphorylates H2AX and triggers MSCI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589157     DOI: 10.1016/j.cub.2004.11.032

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  181 in total

1.  Chromatin configuration and epigenetic landscape at the sex chromosome bivalent during equine spermatogenesis.

Authors:  Claudia Baumann; Christopher M Daly; Sue M McDonnell; Maria M Viveiros; Rabindranath De La Fuente
Journal:  Chromosoma       Date:  2011-01-28       Impact factor: 4.316

2.  Escape of X-linked miRNA genes from meiotic sex chromosome inactivation.

Authors:  Enrique Sosa; Luis Flores; Wei Yan; John R McCarrey
Journal:  Development       Date:  2015-09-22       Impact factor: 6.868

3.  Protein markers of synaptic behavior and chromatin remodeling of the neo-XY body in phyllostomid bats.

Authors:  Mónica I Rahn; Renata C Noronha; Cleusa Y Nagamachi; Julio C Pieczarka; Alberto J Solari; Roberta B Sciurano
Journal:  Chromosoma       Date:  2015-12-11       Impact factor: 4.316

4.  Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.

Authors:  Sang Soo Kim; Liu Cao; Sung-Chul Lim; Cuiling Li; Rui-Hong Wang; Xiaoling Xu; Richard Bachelier; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  BRCA1 associates with the inactive X chromosome in late S-phase, coupled with transient H2AX phosphorylation.

Authors:  Brian P Chadwick; Timothy F Lane
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

6.  Differential expression of sex-linked and autosomal germ-cell-specific genes during spermatogenesis in the mouse.

Authors:  P Jeremy Wang; David C Page; John R McCarrey
Journal:  Hum Mol Genet       Date:  2005-08-23       Impact factor: 6.150

7.  The X and Y chromosomes assemble into H2A.Z-containing [corrected] facultative heterochromatin [corrected] following meiosis.

Authors:  Ian K Greaves; Danny Rangasamy; Michael Devoy; Jennifer A Marshall Graves; David J Tremethick
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 8.  Meiotic silencing and the epigenetics of sex.

Authors:  William G Kelly; Rodolfo Aramayo
Journal:  Chromosome Res       Date:  2007       Impact factor: 5.239

Review 9.  Small RNAs and RNAi pathways in meiotic prophase I.

Authors:  Rebecca J Holmes; Paula E Cohen
Journal:  Chromosome Res       Date:  2007       Impact factor: 5.239

10.  A-MYB (MYBL1) transcription factor is a master regulator of male meiosis.

Authors:  Ewelina Bolcun-Filas; Laura A Bannister; Alex Barash; Kerry J Schimenti; Suzanne A Hartford; John J Eppig; Mary Ann Handel; Lishuang Shen; John C Schimenti
Journal:  Development       Date:  2011-08       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.